Italia markets closed

BMY Aug 2024 45.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,8500-0,0600 (-2,06%)
Alla chiusura: 02:34PM EDT
Schermo intero
Chiusura precedente2,9100
Aperto2,7200
Denaro2,7700
Lettera2,8200
Prezzo d'esercizio45,00
Scadenza2024-08-16
Min-Max giorno2,7000 - 2,9100
Contratto - Min-MaxN/D
Volume28
Open Interest3,91k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri